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Background: Kawasaki disease (KD) is a rare vasculitis seen predominantly in children. In developing countries, it is
the leading cause of childhood-acquired heart disease. Besides a case report from 1981 there have been no data
published dealing with the epidemiology and clinical aspects of KD in Austria.
Methods: The purpose of the present study was to investigate the clinical spectrum of KD in a geographically
determined cohort of infants, children, and adolescents that were diagnosed and treated at the University Hospital
of Innsbruck from 2003–2012.
Results: Thirty-two patients were included in the study with a median age of 32.96 months (2–192). 59.4% of the
patients were aged between six months and four years. The male-to-female ratio was 1:1.13. Clinical examination
revealed non-purulent conjunctivitis and exanthema as the most common symptoms (84.4%). 75% showed
oropharyngeal changes, 21.9% had gastrointestinal complaints such as diarrhoe, stomachache or vomiting prior to
diagnosis. One third of the patients were admitted with a preliminary diagnosis, whereas 78.1% were pre-treated with
antibiotics. The median fever duration at the time of presentation was estimated with 4.96 days (1–14), at time of
diagnosis 6.76 days (3–15).75% were diagnosed with complete KD, and 25% with an incomplete form of the disease.
There was no significant difference in the duration of fever neither between complete and incomplete KD, nor
between the different age groups. Typical laboratory findings included increased C-reactive protein (CRP) (80.6%)
and erythrocyte sedimentation rate (ESR) (96%),leukocytosis (48.4%) and thrombocytosis (40.6%) without any
significant quantitative difference between complete and incomplete KD. Coronary complications could be
observed in six patients: one with a coronary aneurysm and five with tubular dilatation of the coronary arteries. Our
patient cohort represents the age distribution as described in literature and emphasizes that KD could affect persons
of any age. The frequency of occurrence of the clinical symptoms differs from previous reports – in our study, we
predominantly observed non-purulent conjunctivitis and exanthema.
Conclusion: KD should always be considered as a differential diagnosis in a child with fever of unknown origin, as
treatment can significantly decrease the frequency of coronary complications.
Keywords: Kawasaki disease, Clinical symptoms, Fever duration, Age distribution, Coronary complications* Correspondence: Elisabeth.Binder@i-med.ac.at
1Clinic of Pediatrics I, Department of Pediatrics, Medical University Innsbruck,
Anichstrasse 35, 6020 Innsbruck, Austria
Full list of author information is available at the end of the article
© 2014 Binder et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Binder et al. Pediatric Rheumatology 2014, 12:37 Page 2 of 6
http://www.ped-rheum.com/content/12/1/37Background
Kawasaki disease (KD) is the second most common
vasculitis in children. Clinically, KD is characterized by
prolonged fever of at least five days of duration and
certain clinical features, occurring often sequentially in a
non-predefined order [1]. Coronary artery aneurysms as
a sequelae of vasculitis of KD occur in 20–25% of
untreated children. In developing countries, KD has
replaced acute rheumatic fever as the leading cause of
acquired heart disease in children [2,3]. The classic diag-
nosis of KD is based on fever for more than five days
associated with at least four of the five principle features
such as such as polymorphic exanthema, changes of
the oropharynx, bilateral non-purulent conjunctivitis,
cervical lymphadenopathy and changes to the extrem-
ities such as erythema [4]. Besides, some patients do not
meet the classic criteria, showing only some of the
principal features, thus frequently causing a diagnostic
challenge. The term “incomplete KD” describes KD in
children presenting the characteristic fever but less than
four classical diagnostic criteria [5,6]. “Atypical KD” is
defined as KD with any unusual presentation [7] and occurs
more often in infants [8]. Their young age and the potential
for not receiving timely treatment puts them at higher risk
of developing coronary artery lesions [8]. It is also broadly
agreed that KD can be diagnosed in the absence of full
criteria when coronary abnormalities are present [9].
Over 80% occur between the ages of six months and
four years [10]. The low-incidence in the first six months
suggests that most infants are protected by acquired
maternal antibodies. The occurrence of KD is described
1.5 times more common in males than in females [11-13].
The predominant season for KD varies in different coun-
tries. In Europe seasonal peaks are described in winter and
spring [14-16].
KD now occurs in limited regional epidemics [17].
Although, it has been reported in most ethnic groups,
the variation of incidence between countries is striking
[14,16,17]. It is overrepresented among the Asian popu-
lation with an incidence rate in Japan estimated between
120 and 200 cases per 100000 children younger than five
years whereas the incidence in the United States and in
several European countries is reported of 4 to 20 per
100000 children less than five years [14]. The incidence
remains high in those migrating to lower incidence
countries [16]. In general, the incidence of KD appears to
be increasing in a number of countries [11]. In siblings of
affected children it is 10 to 15-fold higher than the popu-
lation incidence [18] and familial occurrence is described
[19]. These observations suggest that disease susceptibility
may be influenced by genetic and cultural factors [20].
The present study was designed to investigate the
clinical spectrum of KD in an entire geographically
determined cohort of pediatric patients.Methods
Data collection
Our investigation is a retrospective study including all
Kawasaki patients, diagnosed and treated between 2003
and 2012 at Innsbruck Medical University (Tyrol, Austria).
This clinic serves a catchment area including the entire
province of Tyrol. Referrals of Kawasaki patients from
other regional hospitals are frequent. The data was col-
lected from patient reports and physician remarks. The
presented research is in compliance with the Helsinki
Declaration.
Statistical analysis
Statistical analyses were performed using SPSS software
version 20.0 for Windows (SPSS Inc. Chicago, IL, USA).
Clinical and patient data (age, gender, duration of fever
until diagnosis or primary presentation, number of patients
with cardiac complications, WBC and platelet counts, CRP
levels) are expressed as median ± range or mean ± standard
deviation (SD). Data distribution was evaluated by means
of histogram analysis and realization of a Shapiro-Wilk
test. For comparison of different groups, the unpaired
T-test or Mann–Whitney U-test was applied when ap-
propriate. Results were regarded as statistically significant
when p < 0.05.
Results
Participants
During the survey period 32 children (n = 32) were diag-
nosed with KD at the University Hospital of Innsbruck.
Based on the clinical based definitions of KD 75% of pa-
tients were diagnosed with complete, 25% with incomplete
KD. Based on the observation that over 80% occur between
the age of six months and four years, we categorized our
patient cohort into three age groups: younger than six
months, six months to four years, and older than four years.
59.4% of our patients were in the group of six months to
four years, whereas 18.8% were younger than six months
and 21.9% older than four years. The median age of the
cohort was 25 months (2.08 years), ranging from 2 months
to 16 years. The male-to-female ratio was 15 vs. 17. 59.4%
of the patients were diagnosed in winter and spring.
Clinical aspects
31.3% of our patients were transferred from a general
practitioner, pediatrician, or another hospital with a
different primary diagnosis such as sepsis, scarlet fever,
exanthema subitum or viral exanthema, superinfection
of a dermatitis, urinary tract-infection, tonsillitis, otitis
media and aphthous stomatitis. In three of our patients
HHV6 could be confirmed whereas one of them suffered
from a Norovirus infection in addition to KD. 78.1% of
our patients were already treated with antibiotics prior
to admission to our outpatient clinic.
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verified by the patient’s report. The mean duration of
fever at primary consultation was 4.95 days (+/−2.97)
with one patient reporting a history of prolonged fever
two weeks despite antibiotic treatment. The mean time
of diagnosis was 6.89 days (+/−3.38) after the fever had
started, including two patients whom were not diag-
nosed before day 15. There was neither significant differ-
ence in the duration of fever until diagnosis between
complete and incomplete KD, nor a significant difference
of the duration of fever among the different age-groups.
Clinical examination revealed that the most common
symptoms were fever (100%), non-purulent conjunctiv-
itis as well as an exanthema (both 84.4%). 75% of the
patients showed changes in lips and oral cavity in-
cluding enanthema (43.8%), red, cracked lips (46.9%)
and strawberry-tongue (18.8%). Cervical lymphadeno-
pathy was observed in 68.8% of all cases. 53.1% of our
patients experienced changes in extremities like palmar
or plantar erythema (Figure 1). 21.9% complained about
gastrointestinal symptoms such as diarrhea, stomach
ache or vomiting.
Laboratory findings
In 81.3% (n = 26, 1 missing data) of our patients an elevated
C-reactive protein (CRP) with a mean value of 11.83 mg/dl
could be measured, 46.2% showing a CRP > 10 mg/dl. In 25
patients the erythrocyte sedimentation rate (ESR) was
measured and showed a mean value of 88.08 mm/h
(12–170 mm/h) after one hour and 114.82 mm/h (34–
170 mm/h) after two hours – besides one patient all of
them had a significant elevated ESR. About half of the
patients (46.9%, 1 missing data) showed a leukocytosis and
40.6% (1 missing data) developed a thrombocytosis while
they were hospitalized. There was no significant difference
regarding laboratory findings (CRP, ESR and leukocytes)
between complete and incomplete KD (p > 0.05).Figure 1 Appearance rate of symptoms of patients diagnosed with KCardiac complications
In total, six patients (18.75%, 1 missing data) had cardiac
complications; five patients experienced tubular dilata-
tion of the coronary arteries and one patient suffered an
aneurysm. Pericardial effusion could be observed in one
patient. The patients with tubular dilatation of the coron-
ary arteries had fever lasting five to 15 days (mean duration
of fever of those patients was 9 +/− 5.04 days).
In the present study in all patients with cardiac
complications ESR was elevated. The patient with the
aneurysm had an ESR of 170/170 mm/h, while the mean
ESR-value of the patients with cardiac complications was
94 (±65.73)/127 (±41.47) mm/h and therefore just slightly
higher than the mean value of 86.6 (+/−47.69)/111.23 mm
(+/−47.06)/h of those without a complication (p > 0.05).
The mean value of the CRP (9.91 mg/dl ±8.70) did not
differ from that of the entire study population (9.98 mg/dl)
(p > 0.05). With the exception of one patient for whom
laboratory values were inconclusive, all of them had
leukocytosis. Three, in addition, developed thrombocytosis
while the disease took its course.
Discussion
This retrospective analysis on KD is the first study of its
kind in Austria. One of the most interesting findings
was that almost one third of patients were transferred to
our hospital with another preliminary diagnosis indica-
ting that KD is often hidden by fever of unknown origin.
However, the average length of time until the beginning
of adequate treatment was only 6.75 days.
The number of the patients is comparable with certain
epidemiologic studies on KD done in other European
countries such as Italy [21], Iceland [22], northern
European countries [23] and the Netherlands [24]. Our
patients showed a balanced male-to-female ratio, which is
different to other studies that usually reveal the predomin-
ance of KD in boys [14,21,23]. This might be explainedD.
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this study, however it represents an entire cohort of
children and adolescents of one region.
According to previous studies, over 80% occur between
the ages of six months and four years [10] whereas a
recently conducted study in northern Europe revealed
only 67,8% of Kawasaki patients younger than 5 years
[23]. In our patient cohort, 59.4% were at the age between
six months and four years and therefore meet the most
common age distribution. The low incidence in the first
six months suggests that most infants are protected by
acquired maternal antibodies [2]. One patient was diag-
nosed with incomplete KD at the age of 192 months,
whereas all the others were younger than 69 months. This
patient was treated successfully with intravenous immu-
noglobin (IVIG) and aspirin and did not suffer from any
complications.
Clinical features like a rash, non-purulent conjunctivitis,
oropharyngeal changes, lymphoadenopathy and changes
to the extremities are known in KD and often appear
sequentially in a non-predefined order [1]. In con-
trast, in our study up to 85% of patients experienced a
non-purulent conjunctivitis and an exanthema. Cervical
lymphadenopathy was observed in 68.8%.
Multiple non-cardiac clinical findings may also be
observed in patients with KD including arthritis or arth-
ralgia [21]. Several of our patients presented with arth-
ralgia, one suffered from painful gonarthritis and coxitis.
Those accompanying, unspecific symptoms often result
in diagnoses other than KD, especially if the patient pre-
sents with the incomplete or atypical type of the illness
and therefore often postpone adequate treatment. Other
unspecific symptoms that may impede prompt diagnosis
are gastrointestinal complaints. Diarrhea, vomiting, and
abdominal pain occur in approximately one-third of
Kawasaki patients [9]. Even if gastrointestinal symptoms
are seen often, mesenteric arteritis is found rarely [24].
Reports of segmental thickening of the small-bowel wall
in the abdominal ultrasound of KD patients are published
[25]. The changes are thought to result from bowel-wall
edema due to vasculitis of the supplying vessels and
might therefore be used as an additional diagnostic sign
in KD. Exactly 21.9% of our patients suffered from gastro-
intestinal symptoms whilst gallbladder hydrops could be
observed only in three of our patients.
Certain common pitfalls in the diagnosis of KD are bac-
terial lymphadenitis, urinary tract infection, viral meningi-
tis, sepsis, and occasionally a child may present acute
abdomen [26]. Almost one-third of our patients were
transferred with a preliminary diagnosis, and even 78.1%
were already treated with, sometimes several different, an-
tibiotics because of fever for one or two days despite a sus-
pected diagnosis for which an antibiotic treatment would
be recommended.Many studies were done to predict the risk of cardiac
involvement in KD [27-29]. In addition to young age [8],
duration of fever (presumably reflecting the severity of
ongoing vasculitis) has been confirmed as a powerful
predictor of coronary artery aneurysms in various stud-
ies [30]. Reflecting the duration of fever until diagnosis
it could be observed that even six patients were diag-
nosed with KD before day five. As the data was collected
from reports and remarks a bias could be the reason for
this observation. Otherwise it prompts the following as
previously investigated question: −can a diagnosis be
made before day five if all other criteria are fulfilled and
could an early IVIG-treatment prevent complications
[31]. None of our patients treated before day five suf-
fered from any cardiac complications. However, because
of the small cohort this observation could only be a co-
incidence. In comparison to an Italian study that shows
how higher values of CRP may play a crucial role in de-
termining the development of coronary complications
[32], our analysis revealed no laboratory value or any
distinct clinical symptom that can be correlated with the
development of coronary aneurysms. An echocardiography
is therefore necessary whenever KD is suspected.
The maximum ESR, the extent of proinflammatory
cytokine production and the degree of neutrophil activa-
tion have been shown to increase the risk of coronary
damage [1]. An investigation in Taiwan showed that the
effects of neutrophil count, dosage of IVIG treatment,
and platelet count (<400 000) in acute coronary artery
lesions in KD are important whereas age, dose of IVIG
treatment and band count are related to the persistence
of coronary lesions in chronic stage [27,33]. Besides the
dose of IVIG also the differences in the manufacturing
process such as purification, preservation and the IgA
content may influence the effectiveness of prevention of
coronary complications [34]. Plasma levels of follistatin-
like protein 1 (FSTL-1), a proinflammatory protein pro-
duced by mesenchymal tissue including cardiac myocytes
was shown to be elevated in patients with acute KD and
may correlate with the development of coronary artery an-
eurysms [35].
Besides leukocytosis, an elevation of ESR, increased
CRP and thrombocytosis [36] plasma lipids are markedly
altered in acute KD, with depressed plasma cholesterol,
high-density lipoprotein (HDL), and apolipoprotein AI
[4]. Hypoalbuminemia is common and urine analysis re-
veals intermittent sterile pyuria in about 33% of patients.
In 2004, the AHA guidelines recommended measuring
ESR, values of CRP, white blood cell count in blood and
urine, platelet count, albumin, hemoglobin, and ALT to
support the diagnosis in KD [9]. Our patients showed la-
boratory values characteristic for KD, however we could
not observe any correlation between laboratory values
and the course of the disease. In conclusion, the diagnosis
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no specific test and the laboratory findings could just sup-
port the clinical suspicion. KD always has to be considered
in a child, adolescent or even adult with fever of unknown
origin.
Conclusion
In conclusion, the diagnosis of KD remains a clinical
one- due to the fact that there is no specific test and the
laboratory findings could just support the clinical suspi-
cion. KD always has to be considered in an infant, child
and adolescent with a fever of unknown origin.
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